Hangzhou sciwind biosciences
WebWe are a fast-growing clinical-stage biopharmaceutical company developing a portfolio of therapeutic candidates for metabolic disease. Our goal is to develop first-in-class and … USA Headquarters. 3001 Bishop Drive, Suite 300 San Ramon, CA 94583, USA. … XW004 is an oral formulation of the GLP-1 peptide analog XW003. To enable oral … Sciwind Biosciences is a fast-growing clinical-stage biopharmaceutical … Prior to founding Sciwind Biosciences, Dr. Pan held leadership roles at Amgen, as … Sciwind Biosciences Announces Positive Topline Results from 20-week Phase 2 … USA Headquarters. 3001 Bishop Drive, Suite 300 San Ramon, California 94583, … USA Headquarters. 3001 Bishop Drive, Suite 300 San Ramon, California 94583, … WebAddress: Room 1802, Building 2, Hangzhou Dongbu International Business Center, Qiantang District Development Zone Hangzhou, Zhejiang, 310000 China See other …
Hangzhou sciwind biosciences
Did you know?
WebSciwind Total Funding $66.5 M Company summary Overview Sciwind (先为达是) is a biotech company that focuses on metabolic diseases, especially fibrotic diseases. It aims to develop therapeutic products for NASH, such as steatohepatitis, liver … WebOct 10, 2024 · HANGZHOU, China and SAN FRANCISCO, Oct. 10, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative ...
WebOct 12, 2024 · HANGZHOU, China and SAN FRANCISCO, Oct. 12, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced the closing of an $70 million Series C financing. WebOct 27, 2024 · Sciwind has developed multiple proprietary technologies, including oral peptide and inhaled protein therapeutic delivery platforms and identified a series of drug candidates based on these core platform technologies. For more information, visit www.sciwindbio.com. SOURCE Hangzhou Sciwind Biosciences Co., Ltd. Posted: …
WebHangzhou Sciwind Biosciences Co. Ltd. operates as a metabolic disease drug developer. The Company researches and develops steatohepatitis, liver fibrosis, cirrhosis, and other … WebSciwind Biosciences is a drug research and development company for metabolic diseases. Hangzhou, Zhejiang, China 51-100 Series C Private www.sciwind.com.cn 43,459 …
WebFeb 19, 2024 · Hangzhou Sciwind Biosciences Co., Ltd., a Hangzhou, China-based clinical-stage biopharmaceutical company focusing on research and development of …
WebNov 30, 2024 · HANGZHOU, China and SAN FRANCISCO, Nov. 30, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on … execution time of a program in pythonWebJan 11, 2024 · Sciwind Biosciences Recent Patent Activity. Publication ID. Patent Title. Status. First Filing Date. Technology (CPC) Citations. AU-2024450589-A1. N- [8- (2-hydroxybenzoyl)amino]potassium octanoate crystal polymorph, and preparation method therefor and use thereof. bsvh facebookWebApr 14, 2024 · HANGZHOU, China and SAN FRANCISCO, April 13, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative ... bsv german club walpoleWebJul 12, 2024 · Sciwind Biosciences is a cross-border biopharmaceutical company focusing on discovering and developing innovative therapies to treat chronic, metabolic and immunological diseases. Its product... bsvg service centerWebFeb 19, 2024 · Hangzhou Sciwind Biosciences Co., Ltd., a Hangzhou, China-based clinical-stage biopharmaceutical company focusing on research and development of innovative biologics, closed a US$37M series B... bsv fork balance creditWebOct 10, 2024 · HANGZHOU, China and SAN FRANCISCO, Oct. 9, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced today the initiation of dosing in a Phase 1 clinical trial evaluating XW014, a novel oral … bsv hamburg athleticonWebFeb 19, 2024 · HANGZHOU, China, Feb. 18, 2024 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. (Sciwind), a clinical-stage, fast-growing biopharmaceutical company focusing on research and development of innovative biologics, today announced the closing of an US$37 Million series B financing. bsvg shop